ID: ALA5281507

Max Phase: Preclinical

Molecular Formula: C15H23NO3

Molecular Weight: 265.35

Associated Items:

Representations

Canonical SMILES:  CCCC1CCN(Cc2oc(C)cc(=O)c2O)CC1

Standard InChI:  InChI=1S/C15H23NO3/c1-3-4-12-5-7-16(8-6-12)10-14-15(18)13(17)9-11(2)19-14/h9,12,18H,3-8,10H2,1-2H3

Standard InChI Key:  ZYHUMROYBCXZOK-UHFFFAOYSA-N

Associated Targets(non-human)

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 265.35Molecular Weight (Monoisotopic): 265.1678AlogP: 2.67#Rotatable Bonds: 4
Polar Surface Area: 53.68Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.49CX Basic pKa: 7.24CX LogP: 2.44CX LogD: 2.19
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.91Np Likeness Score: 0.00

References

1. He M, Fan M, Peng Z, Wang G..  (2021)  An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.,  221  [PMID:34023737] [10.1016/j.ejmech.2021.113546]

Source